Structures by: Mague J. T.
Total: 822
C26H18Cl2N2OSn
C26H18Cl2N2OSn
Dalton transactions (Cambridge, England : 2003) (2014) 43, 47 17754-17765
a=12.2999(15)Å b=10.4788(13)Å c=17.361(2)Å
α=90.00° β=90.753(2)° γ=90.00°
C26H25Cl2N3OSn,CH2Cl2
C26H25Cl2N3OSn,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 47 17754-17765
a=9.4970(6)Å b=11.2897(7)Å c=12.8081(8)Å
α=79.475(2)° β=85.523(2)° γ=89.286(1)°
C22H16Cl2N2OSn
C22H16Cl2N2OSn
Dalton transactions (Cambridge, England : 2003) (2014) 43, 47 17754-17765
a=23.5629(5)Å b=11.2171(2)Å c=16.9265(3)Å
α=90° β=90.4150(10)° γ=90°
C22H15BrCl2N2OSn
C22H15BrCl2N2OSn
Dalton transactions (Cambridge, England : 2003) (2014) 43, 47 17754-17765
a=23.2013(8)Å b=10.8280(4)Å c=28.3103(9)Å
α=90° β=98.767(2)° γ=90°
Μ-(2-(Diphenylphosphanyl)-1-{[2-(diphenylphosphanyl)-1H-imidazole]methyl}-1H-imidazole-κ
C31H26Au2Cl2N4P2,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 40 17696-17703
a=15.155(2)Å b=17.012(3)Å c=26.119(4)Å
α=90° β=90° γ=90°
C93H78Au2ClN12P6,Cl
C93H78Au2ClN12P6,Cl
Dalton transactions (Cambridge, England : 2003) (2015) 44, 40 17696-17703
a=13.2229(3)Å b=26.6831(5)Å c=24.6194(5)Å
α=90° β=95.7770(13)° γ=90°
C18H25N3Nd2O54SiW12,3(H2O)
C18H25N3Nd2O54SiW12,3(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 8824-8832
a=12.6060(19)Å b=12.9593(19)Å c=18.631(3)Å
α=82.317(2)° β=88.815(2)° γ=71.173(2)°
4-[1,3-di-<i>tert</i>-butyl-4-(4,4-dimethylpiperazin-4-ium-1- yl)-2,4-diselanylidene-1,3,2λ^5^,4λ^5^-diazadiphosphedin-2- yl]-1,1-dimethylpiperazin-1-ium iodide hydrate
C20H47N6P2Se2,0.5(OH2),2I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=32.556(3)Å b=9.5372(10)Å c=21.679(2)Å
α=90° β=107.558(2)° γ=90°
1,3-Di-<i>tert</i>-butyl-2,4-bis-<i>tert</i>-butylamino- 2-methyl-4-selenoxo-4λ^5^-[1,3,2,4]diazadiphosphetidin- 2-ium iodide toluene solvate
C24H49N4P2Se,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=9.3436(6)Å b=10.3905(7)Å c=16.7060(13)Å
α=93.176(1)° β=104.556(1)° γ=91.995(1)°
1,3-Di-<i>tert</i>-butyl-2,4-diselenoxy-2λ^5^,4λ^5^- [1,3,2,4]diazadiphosphetidin-2,4-di(yloxyethyl trimethylammonium) Iodode Hydrate
C18H44N4O2P2Se2,2(I),H2O
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=12.1752(9)Å b=14.2395(11)Å c=36.578(3)Å
α=90° β=94.6320(10)° γ=90°
Iodo(2,2-bipyridine-κN:κN')(1,3-di-<i>tert</i>- butyl-2,4-bis(<i>tert</i>-butylamino)-2-methyl-[1,3,2,4] diazadiphosphetidin-2-ium-κP)copper(I) Iodide
C27H49CuIN6P2,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=14.1715(6)Å b=14.6142(6)Å c=16.8817(7)Å
α=90° β=90° γ=90°
Μ-Triiodobis(1,3-di(<i>tert</i>-butyl)-2,4-bis(<i>tert</i>- butylamino)-2-methyl-[1,3,2,4]diazadiphosphetidin- 2-ium)-κ-P dicopper(I) iodide acetonitrile solvate
C34H82Cu2I3N8P4,C2H3N,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=10.3950(7)Å b=29.9149(18)Å c=17.8929(11)Å
α=90° β=95.847(1)° γ=90°
Iodo(1,10-phenanthroline-κN:κN)(1,3-di-<i>tert</i>- butyl-2,4-bis(<i>tert</i>-butylamino)-2-methyl-[1,3,2,4] diazadiphosphetidin-2-ium-κP)copper(I) Iodide
C29H49CuIN6P2,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=24.7202(11)Å b=10.1169(4)Å c=14.2381(6)Å
α=90° β=90° γ=90°
Chlorido{1,3-di-tert-butylbis(tert-butylamino)-2-methyl-1,3,2,4- diazadiphosphetidin-2-ium}gold(I) trifluoromethanesulfonate
C17H41AuClN4P2,CF3O3S
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=9.714(3)Å b=10.396(3)Å c=17.440(6)Å
α=81.865(4)° β=85.488(4)° γ=62.617(4)°
C31H23Au2Cl2NO2P2
C31H23Au2Cl2NO2P2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 9 4167-4179
a=8.4416(18)Å b=17.820(4)Å c=9.883(2)Å
α=90° β=91.510(3)° γ=90°
C43H40Cl4N2O2P2Ru2,CH2Cl2,O
C43H40Cl4N2O2P2Ru2,CH2Cl2,O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 9 4167-4179
a=12.3052(14)Å b=12.6279(14)Å c=15.3356(17)Å
α=90.014(2)° β=93.922(2)° γ=105.059(2)°
C31H23ClNO2P2Rh
C31H23ClNO2P2Rh
Dalton transactions (Cambridge, England : 2003) (2015) 44, 9 4167-4179
a=11.894(3)Å b=14.148(3)Å c=15.675(4)Å
α=90° β=101.663(3)° γ=90°
(6-Diphenyphosphancarbonylpyridin-2-yl)diphenylphosphanylmethanone
C31H23NO2P2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 9 4167-4179
a=15.7730(15)Å b=9.3471(9)Å c=18.1249(17)Å
α=90° β=102.0110(10)° γ=90°
7-Bromo-1,4-dibutyl-1,2,3,4-tetrahydropyrido[2,3-<i>b</i>]pyrazine-2,3-dione
C15H20BrN3O2
IUCrData (2017) 2, 7 x170984
a=22.569(6)Å b=5.1097(13)Å c=13.497(3)Å
α=90° β=90° γ=90°
2-(2-Oxo-4-phenyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-1-yl)acetic acid
C17H14N2O3
IUCrData (2017) 2, 1 x170120
a=17.9752(8)Å b=17.4403(8)Å c=9.2472(4)Å
α=90° β=102.8920(10)° γ=90°
[Pentaaquacobalt(III)]-μ-aspartato-[γ-octamolybdato]-μ-aspartato- [pentaaquacobalt(III)]
C8H32Co2Mo8N2O44,4(H2O)
Acta Crystallographica Section C (2019) 75, 4 469-477
a=11.507(4)Å b=12.853(5)Å c=15.795(6)Å
α=90° β=110.602(5)° γ=90°
Heptacyclo[8.6.6.6^2,9^.0^3,8^.0^11,16^.0^17,22^.0^23,28^]octacosa-3,5,7,11,13,15,17(22),18,20,23(28),24,26-dodecaene-1,9-carbaldehyde
C30H20O2
Acta Crystallographica Section C (2018) 74, 4
a=12.9627(3)Å b=9.6666(2)Å c=16.6887(4)Å
α=90° β=105.2170(11)° γ=90°
Sodium tris[triaqua(μ-1,10-phenanthroline-2,9-dicarboxylato)dysprosium(III)] silicododecatungstate dodecahydrate
C42H18Dy3N6Na1O61.5Si1W12,12(O)
Acta Crystallographica Section C (2018) 74, 11
a=20.3334(3)Å b=20.3334(3)Å c=18.7836(3)Å
α=90° β=90° γ=120°
Sodium aqua tris[tetraaqua(μ-4-hydroxypyridine-2,6-dicarboxylato)praseodymium(III)] silicododecatungstate dodecahydrate
C21H35N3NaO68Pr3SiW12,9(H2O),3O
Acta Crystallographica Section C (2018) 74, 11
a=18.119(3)Å b=18.119(3)Å c=21.078(3)Å
α=90° β=90° γ=120°
1,1'-({[(ethane-1,2-diyl)dioxy](1,2-phenylene)}-bis(methanylylidene))bis(thiosemicarbazide)
C18H20N6O2S2
Acta Crystallographica Section C (2015) 71, 11
a=14.063(2)Å b=17.869(3)Å c=7.8770(12)Å
α=90° β=100.296(2)° γ=90°
1,1'-({[(ethane-1,2-diyl)dioxy](1,2- phenylene)}bis(methanylylidene))bis(thiosemicarbazide) bis(N,N-dimethylformamide) solvate
C18H20N6O2S2,2(C3H7NO)
Acta Crystallographica Section C (2015) 71, 11
a=11.6081(16)Å b=18.136(3)Å c=14.186(2)Å
α=90° β=101.801(2)° γ=90°
Diaqua-bis(pyridine-2-carboxamide-N,O)-nickel(ii) bis(2,6-pyridinedicarboxylato)-nickel(ii) 4.67-hydrate
C14H6N2NiO8,C12H16N4NiO4,4.67(H2O)
Acta Crystallographica Section B (2020) 76, 4
a=10.1294(7)Å b=12.2011(9)Å c=14.2430(11)Å
α=82.035(4)° β=74.232(3)° γ=79.373(3)°
2-(2-Oxo-1,3-oxazolidin-3-yl)ethyl 2-[2-(2-oxo-1,3-oxazolidin-3-yl)ethoxy]quinoline-4-carboxylate
C20H21N3O7
Acta Crystallographica Section E (2021) 77, 1 28-33
a=6.0686(5)Å b=19.2791(15)Å c=16.3795(13)Å
α=90° β=94.185(4)° γ=90°
1-Ethyl-3-phenyl-1,2-dihydroquinoxalin-2-one
C16H14N2O
Acta Crystallographica Section E (2021) 77, 1 18-22
a=9.2572(9)Å b=9.0531(9)Å c=15.0557(14)Å
α=90° β=99.3290(10)° γ=90°
Benzo[1,2-<i>c</i>:3,4-<i>c</i>:5,6-<i>c</i>'']trithiophene—–\ buckminsterfullerene—–toluene
C12H6S3,C60,C7H8
Acta Crystallographica Section E (2019) 75, 10 1573-1577
a=10.0139(6)Å b=17.4327(10)Å c=13.0286(8)Å
α=90° β=108.816(2)° γ=90°
Benzo[1,2-<i>c</i>:3,4-<i>c</i>':5,6-<i>c</i>'']trithiophene--7,7,8,8-tetracyanoquinodimethane
C12H6S3,C12H4N4
Acta Crystallographica Section E (2019) 75, 10 1573-1577
a=14.2567(3)Å b=39.0280(7)Å c=15.2295(3)Å
α=90° β=100.1360(10)° γ=90°
6-Bromo-3-(5-bromohexyl)-2-[4-(dimethylamino)phenyl]-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C20H24Br2N4
Acta Crystallographica Section E (2020) 76, 8 1234-1238
a=8.1488(11)Å b=11.2243(15)Å c=12.6378(17)Å
α=64.049(2)° β=74.184(2)° γ=86.067(2)°
4-[(4-Allyl-2-methoxyphenoxy)methyl]-1-(4-methoxyphenyl)-1<i>H</i>-1,2,3-triazole
C20H21N3O3
Acta Crystallographica Section E (2020) 76, 6 962-966
a=16.212(3)Å b=5.9584(12)Å c=19.450(4)Å
α=90° β=110.537(3)° γ=90°
(<i>Z</i>)-4-Hexyl-2-(4-methylbenzylidene)-2<i>H</i>-benzo[<i>b</i>][1,4]thiazin-3(4<i>H</i>)-one
C22H25NOS
Acta Crystallographica Section E (2020) 76, 6 889-895
a=8.8581(19)Å b=9.183(2)Å c=13.021(3)Å
α=106.474(3)° β=109.398(3)° γ=93.383(3)°
6-Bromo-3-(12-bromododecyl)-2-(4-nitrophenyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine
C24H30Br2N4O2
Acta Crystallographica Section E (2020) 76, 5 677-682
a=6.3291(11)Å b=9.8911(17)Å c=21.133(4)Å
α=76.480(2)° β=84.965(3)° γ=73.891(2)°
Hexyl 1-hexyl-2-oxo-1,2-dihydroquinoline-4-carboxylate
C22H31NO3
Acta Crystallographica Section E (2020) 76, 5 642-645
a=17.6928(7)Å b=13.2512(5)Å c=8.5916(3)Å
α=90° β=90.184(2)° γ=90°
Ethyl 2-[(2<i>Z</i>)-2-(2-chlorobenzylidene)-3-oxo-3,4-dihydro-2<i>H</i>-\ 1,4-benzothiazin-4-yl]acetate
C19H16ClNO3S
Acta Crystallographica Section E (2020) 76, 5 629-636
a=11.6882(2)Å b=9.0903(2)Å c=16.9533(3)Å
α=90° β=105.1050(10)° γ=90°
Ammonium μ-oxido-μ-[1,5,6-trihydroxyhexane-2,3,4-tris(olato)]bis[dioxidomolybdenum(V)] monohydrate
H4N,C6H11Mo2O11,H2O
Acta Crystallographica Section E (2020) 76, 4 518-522
a=8.1775(17)Å b=6.7722(14)Å c=12.305(3)Å
α=90° β=99.664(3)° γ=90°
1,3-Bis[2-methoxy-4-(prop-2-en-1-yl)phenoxy]propane
C23H28O4
Acta Crystallographica Section E (2020) 76, 3 344-348
a=15.4741(5)Å b=5.0224(2)Å c=25.5180(9)Å
α=90° β=99.858(2)° γ=90°
1-(1,3-Benzothiazol-2-yl)-3-(2-hydroxyethyl)imidazolidin-2-one
C12H13N3O2S
Acta Crystallographica Section E (2020) 76, 3 370-376
a=7.2863(2)Å b=13.9178(5)Å c=11.6156(4)Å
α=90° β=98.8660(10)° γ=90°
(2<i>Z</i>)-2-(2,4-Dichlorobenzylidene)-4-nonyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C24H27Cl2NOS
Acta Crystallographica Section E (2020) 76, 2 281-287
a=8.9961(3)Å b=10.3755(3)Å c=13.2565(4)Å
α=73.8570(10)° β=88.1190(10)° γ=74.1820(10)°
2,2,5-Trimethyl-1,3-dioxane-5-carboxylic acid
C8H14O4
Acta Crystallographica Section E (2020) 76, 1 86-90
a=16.9457(8)Å b=9.6453(5)Å c=12.1052(6)Å
α=90° β=116.9860(10)° γ=90°
2,2,5-Trimethyl-1,3-dioxane-5-carboxylic anhydride
C16H26O7
Acta Crystallographica Section E (2020) 76, 1 86-90
a=10.355(4)Å b=11.928(5)Å c=14.496(6)Å
α=73.128(5)° β=84.900(5)° γ=89.499(6)°
1-Benzyl-3-[(1-benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one monohydrate
C24H21N5O,H2O
Acta Crystallographica Section E (2020) 76, 1 95-101
a=9.0872(2)Å b=21.1012(4)Å c=11.7134(2)Å
α=90° β=112.6540(10)° γ=90°
Ethyl (2<i>S</i>,3<i>R</i>)-3-(3-amino-1<i>H</i>-1,2,4-triazol-1-yl)-2-hydroxy-3-phenylpropanoate
C13H16N4O3
Acta Crystallographica Section E (2019) 75, 12 1919-1924
a=8.4766(2)Å b=9.4841(2)Å c=16.9904(3)Å
α=90° β=94.3080(10)° γ=90°
1-Methyl-3-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C11H10N2O
Acta Crystallographica Section E (2019) 75, 12 1940-1946
a=7.1507(3)Å b=8.8177(4)Å c=15.4602(7)Å
α=90° β=97.914(2)° γ=90°
Methyl 4-[3,6-bis(pyridin-2-yl)pyridazin-4-yl]benzoate
C22H16N4O2
Acta Crystallographica Section E (2019) 75, 11 1672-1678
a=6.04640(10)Å b=11.7175(3)Å c=13.2931(3)Å
α=95.7350(10)° β=95.8130(10)° γ=101.7800(10)°
(2<i>Z</i>)-4-Benzyl-2-(2,4-dichlorobenzylidene)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C22H15Cl2NOS
Acta Crystallographica Section E (2019) 75, 11 1650-1656
a=9.0373(7)Å b=16.6798(13)Å c=12.5110(10)Å
α=90° β=95.982(2)° γ=90°
<i>N</i>-(<i>tert</i>-butyl)-2-(phenylethynyl)imidazo[1,2-<i>a</i>]pyridin-3-\ amine
C19H19N3
Acta Crystallographica Section E (2019) 75, 10 1564-1567
a=9.3492(2)Å b=16.3716(3)Å c=10.8030(2)Å
α=90° β=90° γ=90°
3,4-Dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine
C20H17N3O3
Acta Crystallographica Section E (2019) 75, 1 94-98
a=10.509(9)Å b=7.435(6)Å c=21.367(16)Å
α=90° β=103.041(15)° γ=90°
2-(1-decyl-2-oxoindolin-3-ylidene)propanedinitrile
C21H25N3O
Acta Crystallographica Section E (2019) 75, 1 21-25
a=44.4837(12)Å b=4.72930(10)Å c=18.3432(5)Å
α=90° β=106.965(2)° γ=90°
4-Dichloromethyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-2-one
C10H8Cl2N2O
Acta Crystallographica Section E (2019) 75, 1 33-37
a=12.1783(6)Å b=5.7217(3)Å c=14.8258(7)Å
α=90° β=95.7400(10)° γ=90°
1-[(1-Butyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-3-methylquinoxalin-2(1<i>H</i>)-one
C16H19N5O
Acta Crystallographica Section E (2018) 74, 12 1815-1820
a=5.3265(2)Å b=9.9946(4)Å c=14.5414(5)Å
α=103.054(2)° β=100.039(2)° γ=93.108(2)°
5-Methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidine
C6H6N4
Acta Crystallographica Section E (2018) 74, 12 1833-1837
a=3.7910(2)Å b=18.0092(10)Å c=9.0069(5)Å
α=90° β=101.704(2)° γ=90°
1-Benzyl-3-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C17H14N2O
Acta Crystallographica Section E (2018) 74, 12 1842-1846
a=8.3567(2)Å b=9.2040(2)Å c=17.7868(4)Å
α=90° β=94.5590(10)° γ=90°
3-(4-Methylphenyl)-6-nitro-1<i>H</i>-indazole
C14H11N3O3
Acta Crystallographica Section E (2018) 74, 12 1857-1861
a=14.1447(14)Å b=11.8380(12)Å c=7.4252(8)Å
α=90° β=96.681(7)° γ=90°
1-{[2-Oxo-3-(prop-1-en-2-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-1-yl)methyl}-3-(prop-1-en-2-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C21H20N4O2
Acta Crystallographica Section E (2018) 74, 12 1746-1750
a=11.5244(5)Å b=8.6312(4)Å c=17.9845(8)Å
α=90° β=94.1340(10)° γ=90°
Ethyl 2-[2-((1<i>E</i>)-{(1<i>E</i>)-2-[2-(2-ethoxy-2-oxoethoxy)benzylidene]hydrazin-1-ylidene}methyl)phenoxy]acetate
C22H24N2O6
Acta Crystallographica Section E (2015) 71, 1 o16
a=18.2073(5)Å b=11.7758(3)Å c=9.9950(3)Å
α=90° β=93.2260(10)° γ=90°
Methyl 2-hydroxy-5-[(4-oxo-4,5-dihydro-1,3-thiazol-2-yl)amino]benzoate
C11H10N2O4S
Acta Crystallographica Section E (2015) 71, 5 o282-o283
a=4.77870(10)Å b=25.4128(7)Å c=18.9599(5)Å
α=90° β=90.8410(10)° γ=90°
Poly[di-μ-aqua-{5-[(1<i>Z</i>)-2-(4-chlorophenyl)-1-cyanoethenyl]-1,2,\ 3,4-tetrazol-1-ido-κ<i>N</i>^1^}sodium]
C10H9ClN5NaO2
Acta Crystallographica Section E (2015) 71, 5 m102-m103
a=22.0438(4)Å b=3.83430(10)Å c=15.0141(3)Å
α=90° β=92.4270(10)° γ=90°
1-{3-Acetyl-2-(4-chlorophenyl)-6-hydroxy-4-[(2-hydroxypropyl)amino]-6-methylcyclohex-3-en-1-yl}ethanone
C20H26ClNO4
Acta Crystallographica Section E (2015) 71, 5 o369-o370
a=5.5490(2)Å b=8.7759(3)Å c=19.4428(6)Å
α=90° β=92.815(2)° γ=90°
2-(11-Oxo-10<i>H</i>,11<i>H</i>-indeno[1,2-<i>b</i>]chromen-10-yl)-2,3-dihydro-1<i>H</i>-indene-1,3-dione
C25H14O4
Acta Crystallographica Section E (2015) 71, 5 o333-o334
a=8.7409(2)Å b=14.4740(3)Å c=14.2774(3)Å
α=90° β=101.1410(10)° γ=90°
2-(5-Bromo-2-hydroxybenzylidene)-2,3-dihydro-1<i>H</i>-indene-1,3-dione
C16H9BrO3
Acta Crystallographica Section E (2015) 71, 5 o324-o325
a=13.8820(4)Å b=3.86950(10)Å c=24.0068(5)Å
α=90° β=102.4830(10)° γ=90°
5-(4-Methylphenyl)-3-[(<i>E</i>)-2-(4-methylphenyl)ethenyl]cyclohex-2-en-1-one
C22H22O
Acta Crystallographica Section E (2015) 71, 6 o372-o373
a=4.96140(10)Å b=30.7302(6)Å c=11.0726(2)Å
α=90° β=93.2680(10)° γ=90°
4-Bromo-2-[(<i>E</i>)-<i>N</i>-(2,2,6,6-tetramethylpiperidin-4-yl)carboximidoyl]phenol dihydrate
C16H23BrN2O,2(H2O)
Acta Crystallographica Section E (2015) 71, 5 o349-o350
a=39.6126(7)Å b=6.04970(10)Å c=14.8673(3)Å
α=90° β=98.8890(10)° γ=90°
1,2-Di-<i>tert</i>-butyl-1,1,2,2-tetraphenyldisilane
C32H38Si2
Acta Crystallographica Section E (2017) 73, 3 448-452
a=8.5622(5)Å b=10.2107(6)Å c=15.4586(10)Å
α=90° β=95.4520(10)° γ=90°
1,1,2,2-Tetrabromoisopropyl-1,2-diphenyldisilane
C24H34Br4Si2
Acta Crystallographica Section E (2017) 73, 3 448-452
a=8.8779(7)Å b=10.4042(8)Å c=29.699(2)Å
α=90° β=90.9750(10)° γ=90°
1,1,2,2-Tetraisopropyl-1,2-diphenyldisilane
C24H38Si2
Acta Crystallographica Section E (2017) 73, 3 448-452
a=19.8418(14)Å b=8.2554(6)Å c=28.454(2)Å
α=90° β=97.8380(10)° γ=90°
(4<i>Z</i>)-1-Butyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C16H20N2O2
Acta Crystallographica Section E (2018) 74, 11 1669-1673
a=9.1132(6)Å b=12.6676(9)Å c=12.8164(9)Å
α=91.3440(10)° β=99.5370(10)° γ=96.3400(10)°
Ethyl 2-{4-[(3-methyl-2-oxo-1,2-dihydroquinoxalin-1-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate
C16H17N5O3
Acta Crystallographica Section E (2018) 74, 11 1648-1652
a=7.2061(15)Å b=10.237(2)Å c=10.694(2)Å
α=95.356(3)° β=92.867(3)° γ=100.291(3)°
2-Cyano-1-methylpyridinium hexafluoridophosphate
C7H7N2,F6P
Acta Crystallographica Section E (2018) 74, 9 1322-1329
a=6.5296(5)Å b=15.7145(13)Å c=9.5550(7)Å
α=90° β=93.327(4)° γ=90°
3-Cyano-1-methylpyridinium hexafluoridophosphate
C7H7N2,F6P
Acta Crystallographica Section E (2018) 74, 9 1322-1329
a=7.8484(2)Å b=10.8964(2)Å c=11.8669(3)Å
α=90° β=90° γ=90°
4-Cyano-1-methylpyridinium hexafluoridophosphate
C7H7N2,F6P
Acta Crystallographica Section E (2018) 74, 9 1322-1329
a=8.5293(6)Å b=8.6264(7)Å c=13.3589(10)Å
α=90° β=90° γ=90°
(2<i>Z</i>)-2-(2,4-Dichlorobenzylidene)-4-[2-(2-oxo-1,3-oxazolidin-3-yl)ethyl]-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C20H16Cl2N2O3S
Acta Crystallographica Section E (2019) 75, 5 593-599
a=18.4615(8)Å b=12.8567(5)Å c=7.9251(4)Å
α=90° β=96.926(2)° γ=90°
(2<i>Z</i>)-2-(4-Fluorobenzylidene)-4-(prop-2-yn-1-yl)-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C18H12FNOS
Acta Crystallographica Section E (2019) 75, 3 372-377
a=4.0602(2)Å b=13.8983(5)Å c=14.2620(5)Å
α=117.809(2)° β=93.155(2)° γ=94.416(2)°
Ethyl 2-(4-benzyl-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl)acetate
C16H18N2O3
Acta Crystallographica Section E (2019) 75, 3 392-396
a=7.4069(9)Å b=8.1959(10)Å c=24.133(3)Å
α=90° β=90.295(2)° γ=90°
<i>N</i>-{2-[(<i>E</i>)-(4-Methylbenzylidene)amino]phenyl}-2-(5-methyl-1-<i>H</i>-pyrazol-3-yl)acetamide hemihydrate
C20H20N4O,0.5(H2O)
Acta Crystallographica Section E (2019) 75, 2 154-158
a=11.546(3)Å b=12.564(3)Å c=13.172(3)Å
α=101.991(3)° β=97.535(3)° γ=99.847(3)°
Enzyl 1-benzyl-2-oxo-1,2-dihydroquinoline-4-carboxylate
C24H19NO3
Acta Crystallographica Section E (2019) 75, 7 980-983
a=5.6101(4)Å b=19.5523(11)Å c=17.2761(11)Å
α=90° β=96.969(5)° γ=90°
3-{(2<i>Z</i>)-2-[(2,4-Dichlorophenyl)methylidene]-3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl}propanenitrile
C18H12Cl2N2OS
Acta Crystallographica Section E (2019) 75, 6 721-727
a=6.5687(6)Å b=7.9971(7)Å c=15.4939(13)Å
α=98.105(4)° β=94.316(4)° γ=95.002(4)°
3-(4-Methoxyphenyl)-1-methyl-4-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C19H16N4O
Acta Crystallographica Section E (2019) 75, 5 638-641
a=6.5227(3)Å b=7.8979(4)Å c=30.7774(15)Å
α=90° β=95.389(2)° γ=90°
2-Chloroethyl 2-oxo-1-(prop-2-yn-1-yl)-1,2-dihydroquinoline-4-carboxylate
C15H12ClNO3
Acta Crystallographica Section E (2019) 75, 10 1411-1417
a=7.1809(2)Å b=21.4466(5)Å c=8.9173(2)Å
α=90° β=92.784(2)° γ=90°
4-[(Prop-2-en-1-yloxy)methyl]-3,6-bis(pyridin-2-yl)pyridazine
C18H16N4O
Acta Crystallographica Section E (2019) 75, 9 1321-1326
a=8.9420(2)Å b=15.1130(3)Å c=11.5829(3)Å
α=90° β=100.1320(10)° γ=90°
1-Nonyl-2,3-dihydro-1<i>H</i>-indole-2,3-dione
C17H23NO2
Acta Crystallographica Section E (2019) 75, 8 1140-1144
a=16.2512(4)Å b=7.6859(2)Å c=13.0989(3)Å
α=90° β=106.6400(10)° γ=90°
3-Methyl-1-phenyl-5-(1<i>H</i>-pyrrol-1-yl)-1<i>H</i>-pyrazole-4-carbaldehyde
C15H13N3O
Acta Crystallographica Section E (2014) 70, 10 o1131-o1132
a=9.5807(8)Å b=15.1720(13)Å c=8.7370(8)Å
α=90° β=93.6180(11)° γ=90°
2-Amino-4-(4-methoxyphenyl)-4<i>H</i>-benzo[<i>g</i>]chromene-3-carbonitrile
C21H16N2O2
Acta Crystallographica Section E (2015) 71, 12 o1017-o1018
a=6.3833(2)Å b=10.6009(3)Å c=13.0915(4)Å
α=108.823(2)° β=95.906(2)° γ=97.467(2)°
(<i>Z</i>)-Ethyl 2-{5-[(2-benzylidene-3-oxo-2,3-dihydrobenzo[<i>b</i>][1,4]thiazin-4-yl)methyl]-1<i>H</i>-1,2,3-triazol-1-yl}acetate
C22H20N4O3S
Acta Crystallographica Section E (2015) 71, 12 o1022-o1023
a=9.9767(6)Å b=8.7342(5)Å c=23.1027(14)Å
α=90° β=94.5080(10)° γ=90°
<i>N</i>-[(8<i>E</i>)-12-Methyl-14-phenyl-10,13,14,16-tetraazatetracyclo[7.7.0.0^2,7^.0^11,15^]hexadeca-1(16),2,4,6,9,11(15),12-heptaen-8-ylidene]hydroxylamine 1,4-dioxane hemisolvate
C19H13N5O,0.5(C4H8O2)
Acta Crystallographica Section E (2015) 71, 2 o75-o76
a=15.8019(4)Å b=5.56750(10)Å c=20.4756(5)Å
α=90° β=102.093(2)° γ=90°
Ethyl 2-(2-{(1<i>E</i>)-[(<i>E</i>)-2-(2-hydroxybenzylidene)hydrazin-1-ylidene]methyl}phenoxy)acetate
C18H18N2O4
Acta Crystallographica Section E (2015) 71, 2 o70-o71
a=17.6846(4)Å b=4.86450(10)Å c=19.2235(4)Å
α=90° β=107.3570(10)° γ=90°
1-(2-Aminophenyl)-3-phenylurea
C13H13N3O
Acta Crystallographica Section E (2015) 71, 2 o88-o89
a=16.1742(4)Å b=4.56670(10)Å c=16.3259(4)Å
α=90° β=106.5480(10)° γ=90°
(5<i>Z</i>)-5-(5-Bromo-2-hydroxybenzylidene)-1,3-thiazolidine-2,4-dione
C10H6BrNO3S
Acta Crystallographica Section E (2015) 71, 12 o919-o920
a=7.0680(7)Å b=7.6770(8)Å c=9.9977(10)Å
α=68.119(2)° β=86.0490(10)° γ=83.6580(10)°
Ethyl 2-{2-[(1<i>Z</i>)-1-hydroxy-3-(4-nitrophenyl)-3-oxoprop-1-en-1-yl]phenoxy}acetate
C19H17NO7
Acta Crystallographica Section E (2015) 71, 12 o917-o918
a=4.7818(10)Å b=16.260(3)Å c=21.948(5)Å
α=90° β=95.933(3)° γ=90°
2-Cyano-1-methylpyridinium perchlorate
C7H7N2,ClO4
Acta Crystallographica Section E (2015) 71, 11 o852-o853
a=8.0112(12)Å b=7.7011(12)Å c=14.742(2)Å
α=90° β=90.982(2)° γ=90°
(4-Methoxyphenyl)[(4-methoxyphenyl)phosphonato]dioxidophosphate(1-) 2-amino-6-benzyl-3-ethoxycarbonyl-4,5,6,7-tetrahydrothieno[2,3-<i>c</i>]pyridin-6-ium
C17H21N2O2S,C14H15O7P2
Acta Crystallographica Section E (2015) 71, 12 o997-o998
a=12.443(2)Å b=15.194(3)Å c=17.856(3)Å
α=107.099(2)° β=90.376(2)° γ=96.899(2)°
4-Benzyl-2<i>H</i>-benzo[<i>b</i>][1,4]thiazin-3(4<i>H</i>)-one
C15H13NOS
Acta Crystallographica Section E (2015) 71, 12 o999
a=10.8711(7)Å b=5.3815(3)Å c=21.1997(13)Å
α=90° β=93.1280(10)° γ=90°
2-Oxo-<i>N</i>'-phenyl-2<i>H</i>-chromene-3-carbohydrazide
C16H12N2O3
Acta Crystallographica Section E (2015) 71, 12 o1005-o1006
a=6.6508(2)Å b=8.3906(3)Å c=11.6388(4)Å
α=96.504(2)° β=95.614(2)° γ=94.757(2)°
3-(Prop-2-en-1-yl)-1-{[(1<i>E</i>)-1,2,3,4-tetrahydronaphthalen-1-ylidene]amino}thiourea
C14H17N3S
Acta Crystallographica Section E (2015) 71, 12 o976-o977
a=7.6665(2)Å b=8.5788(2)Å c=20.4072(5)Å
α=90° β=91.7940(10)° γ=90°
3-Benzyl-1-[(1,2,3,4-tetrahydronaphthalen-1-ylidene)amino]thiourea
C18H19N3S
Acta Crystallographica Section E (2015) 71, 12 o974-o975
a=11.9129(5)Å b=9.6914(4)Å c=27.8220(11)Å
α=90° β=90° γ=90°
(5<i>Z</i>)-5-(2-Hydroxybenzylidene)-1,3-thiazolidine-2,4-dione
C10H7NO3S
Acta Crystallographica Section E (2015) 71, 12 o965-o966
a=7.2040(7)Å b=13.6544(14)Å c=18.9346(18)Å
α=90.226(2)° β=95.531(2)° γ=91.330(2)°
4-[(<i>E</i>)-(4-Hydroxybenzylidene)amino]-1,5-dimethyl-2-phenyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C18H17N3O2
Acta Crystallographica Section E (2015) 71, 12 o947-o948
a=8.1214(7)Å b=12.5405(10)Å c=23.1875(19)Å
α=91.1210(10)° β=90.1990(10)° γ=90.7480(10)°
3-Benzyl-1-[(cyclohexylidene)amino]thiourea
C14H19N3S
Acta Crystallographica Section E (2015) 71, 12 o933-o934
a=6.5537(3)Å b=10.5247(5)Å c=11.3403(5)Å
α=113.6820(10)° β=92.969(2)° γ=106.610(2)°